• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于原发性不明癌症的基因表达肿瘤分类器的开发与验证

Development and validation of a gene expression tumour classifier for cancer of unknown primary.

作者信息

Tothill Richard W, Shi Fan, Paiman Lisa, Bedo Justin, Kowalczyk Adam, Mileshkin Linda, Buela Evangeline, Klupacs Robert, Bowtell David, Byron Keith

机构信息

1Peter MacCallum Cancer Centre, East Melbourne 2National (ICT) Australia, The University of Melbourne, Parkville 3Healthscope Pathology, Clayton 4Circadian Technologies Limited, Toorak 5The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 6The Department of Pathology, University of Melbourne, Parkville 7The Department of Biochemistry, University of Melbourne, Parkville, Vic, Australia.

出版信息

Pathology. 2015 Jan;47(1):7-12. doi: 10.1097/PAT.0000000000000194.

DOI:10.1097/PAT.0000000000000194
PMID:25485653
Abstract

Accurate identification of the primary tumour in cancer of unknown primary (CUP) is required for effective treatment selection and improved patient outcomes. The aim of this study was to develop and validate a gene expression tumour classifier and integrate it with histopathology to identify the likely site of origin in CUP.RNA was extracted from 450 formalin fixed, paraffin embedded samples of known origin comprising 18 tumour groups. Whole genome expression analysis was performed using a bead-based array. Classification of the tumours made use of a binary support vector machine, together with recursive feature elimination. A hierarchical tumour classifier was developed and incorporated with conventional histopathology to identify the origins of metastatic tumours.The classifier demonstrated an accuracy of 88% for correctly predicting the tumour type on a validation set of known tumours (n = 94). For CUP samples (n = 49) having a final clinical diagnosis, the classifier improved the accuracy of histology alone for both single and multiple predictions. Furthermore, where histology alone could not suggest any specific diagnosis, the classifier was able to correctly predict the primary site of origin.We demonstrate the integration of gene expression profiling with conventional histopathology to aid the investigation of CUP.

摘要

准确识别原发性不明癌症(CUP)中的原发肿瘤对于有效选择治疗方案和改善患者预后至关重要。本研究的目的是开发并验证一种基因表达肿瘤分类器,并将其与组织病理学相结合,以确定CUP中可能的肿瘤起源部位。从450个已知起源的福尔马林固定、石蜡包埋样本中提取RNA,这些样本包括18个肿瘤组。使用基于微珠的芯片进行全基因组表达分析。肿瘤分类采用二元支持向量机,并结合递归特征消除。开发了一种分层肿瘤分类器,并将其与传统组织病理学相结合,以确定转移性肿瘤的起源。该分类器在一组已知肿瘤的验证集(n = 94)上对肿瘤类型进行正确预测的准确率为88%。对于具有最终临床诊断的CUP样本(n = 49),该分类器提高了单纯组织学对单个和多个预测的准确性。此外,在单纯组织学无法给出任何具体诊断的情况下,该分类器能够正确预测原发起源部位。我们展示了基因表达谱与传统组织病理学的整合,以辅助CUP的研究。

相似文献

1
Development and validation of a gene expression tumour classifier for cancer of unknown primary.一种用于原发性不明癌症的基因表达肿瘤分类器的开发与验证
Pathology. 2015 Jan;47(1):7-12. doi: 10.1097/PAT.0000000000000194.
2
Efficient identification of miRNAs for classification of tumor origin.高效识别 microRNA 用于肿瘤来源分类。
J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.
3
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.一种基于表达的起源部位诊断方法,专为临床应用于不明起源癌症而设计。
Cancer Res. 2005 May 15;65(10):4031-40. doi: 10.1158/0008-5472.CAN-04-3617.
4
An integrated tool for determining the primary origin site of metastatic tumours.一种用于确定转移性肿瘤原发部位的综合工具。
J Clin Pathol. 2018 Jul;71(7):584-593. doi: 10.1136/jclinpath-2017-204887. Epub 2017 Dec 16.
5
Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.通过源自正常组织的基因表达特征预测肿瘤的起源部位。
Oncogene. 2010 Aug 5;29(31):4485-92. doi: 10.1038/onc.2010.196. Epub 2010 May 31.
6
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.大规模平行测序有助于不明原发癌的诊断和靶向治疗。
J Pathol. 2013 Dec;231(4):413-23. doi: 10.1002/path.4251.
7
Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.一种用于未知原发灶癌症的基于微阵列的新型诊断测试的实施。
Int J Cancer. 2009 Sep 15;125(6):1390-7. doi: 10.1002/ijc.24504.
8
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.基因表达谱分析以确定原发灶不明的转移性腺癌的组织发生来源。
J Clin Oncol. 2008 Sep 20;26(27):4435-41. doi: 10.1200/JCO.2007.14.6969.
9
[Molecular diagnostic methods designed for clinical approach to cancer of unknown origin].[用于对不明原发癌进行临床诊断的分子诊断方法]
Gan To Kagaku Ryoho. 2009 Jun;36(6):923-6.
10
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.基于基因表达微阵列测试鉴定不明原发癌的组织来源。
Diagn Pathol. 2010 Jan 13;5:3. doi: 10.1186/1746-1596-5-3.

引用本文的文献

1
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.重新审视原发灶不明的癌症:从诊断挑战到靶向治疗
Nat Rev Clin Oncol. 2025 Aug 4. doi: 10.1038/s41571-025-01060-8.
2
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling.GPSai:一种在常规肿瘤分析中用于预测组织起源的经过临床验证的人工智能工具。
Cancer Res Commun. 2025 Sep 1;5(9):1477-1489. doi: 10.1158/2767-9764.CRC-25-0171.
3
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.
全基因组测序可改善原发灶不明癌症的组织来源诊断及治疗方案。
Nat Commun. 2025 May 20;16(1):4422. doi: 10.1038/s41467-025-59661-x.
4
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.精准医学时代未知原发灶癌症的诊断与治疗进展
MedComm (2020). 2025 Apr 16;6(5):e70161. doi: 10.1002/mco2.70161. eCollection 2025 May.
5
Tracing unknown tumor origins with a biological-pathway-based transformer model.基于生物途径的变换模型追踪未知肿瘤起源。
Cell Rep Methods. 2024 Jun 17;4(6):100797. doi: 10.1016/j.crmeth.2024.100797.
6
A review on trends in development and translation of omics signatures in cancer.癌症中组学特征的发展与转化趋势综述。
Comput Struct Biotechnol J. 2024 Feb 3;23:954-971. doi: 10.1016/j.csbj.2024.01.024. eCollection 2024 Dec.
7
New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.精准医学时代识别不明原发癌组织来源的新技术:进展与挑战。
Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae028.
8
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.比较 DNA 测序和基因表达谱分析以辅助不明原发癌的组织起源诊断。
J Pathol. 2023 Jan;259(1):81-92. doi: 10.1002/path.6022. Epub 2022 Nov 30.
9
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.全面的基因组和表观基因组分析在不明原发癌症中指导了基于分子特征的治疗,尽管存在异质性。
Nat Commun. 2022 Aug 2;13(1):4485. doi: 10.1038/s41467-022-31866-4.
10
Psychological distress, understanding of cancer and illness uncertainty in patients with Cancer of Unknown Primary.原发灶不明癌患者的心理困扰、对癌症和疾病不确定性的认识。
Psychooncology. 2022 Nov;31(11):1869-1876. doi: 10.1002/pon.5990. Epub 2022 Jul 3.